| Dr Richard Gerard Schmitt, MD | |
|
12502 Willowbrook Rd, S, Cumberland, MD 21502-6393 | |
| (240) 964-8690 | |
| (240) 964-8699 |
| Full Name | Dr Richard Gerard Schmitt |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 48 Years |
| Location | 12502 Willowbrook Rd, Cumberland, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336271667 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | D26333 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sentara Williamsburg Regional Medical Center | Williamsburg, VA | Hospital |
| Western Maryland Regional Medical Center | Cumberland, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Upmc Western Maryland Health Services Llc | 7113396011 | 151 |
News Archive
According to a recent study, following a high Glycemic Index (GI) diet may increase a persons risk of fatty liver disease.
To discriminate between patients with severe and non-severe COVID-19 quickly, researchers from Peru looked for prognostic signatures in the blood samples of COVID-19 patients. Virgilio E. Failoc-Rojas et al. examined laboratory results and clinical prognosis of COVID-19 patients from a hospital in the Peruvian Amazon.
Serono and IVAX Corporation has announced positive results from two clinical trials with a new proprietary oral formulation of cladribine, a potential new treatment for multiple sclerosis (MS). The study results showed that the formulation of oral cladribine which has been developed by Serono and IVAX has met the targets for an orally administered product, with blood levels of cladribine in the expected therapeutic range. Efficacy studies of oral cladribine in MS patients are planned to start late 2004.
Ten months into the coronavirus disease (COVID-19) pandemic, health experts have a good understanding of how the virus spreads. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spreads through respiratory droplets and aerosols and enters the body through the mouth, nose, and eyes.
Certain fragments of DNA shed by tumors into the bloodstream can potentially be used to non-invasively screen for early-stage cancers, monitor responses to treatment and help explain why some cancers are resistant to therapies, according to results of an international study led by Johns Hopkins Kimmel Cancer Center investigators.
› Verified 6 days ago
| Entity Name | Upmc Western Maryland Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184769952 PECOS PAC ID: 7113900655 Enrollment ID: O20040608000157 |
News Archive
According to a recent study, following a high Glycemic Index (GI) diet may increase a persons risk of fatty liver disease.
To discriminate between patients with severe and non-severe COVID-19 quickly, researchers from Peru looked for prognostic signatures in the blood samples of COVID-19 patients. Virgilio E. Failoc-Rojas et al. examined laboratory results and clinical prognosis of COVID-19 patients from a hospital in the Peruvian Amazon.
Serono and IVAX Corporation has announced positive results from two clinical trials with a new proprietary oral formulation of cladribine, a potential new treatment for multiple sclerosis (MS). The study results showed that the formulation of oral cladribine which has been developed by Serono and IVAX has met the targets for an orally administered product, with blood levels of cladribine in the expected therapeutic range. Efficacy studies of oral cladribine in MS patients are planned to start late 2004.
Ten months into the coronavirus disease (COVID-19) pandemic, health experts have a good understanding of how the virus spreads. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spreads through respiratory droplets and aerosols and enters the body through the mouth, nose, and eyes.
Certain fragments of DNA shed by tumors into the bloodstream can potentially be used to non-invasively screen for early-stage cancers, monitor responses to treatment and help explain why some cancers are resistant to therapies, according to results of an international study led by Johns Hopkins Kimmel Cancer Center investigators.
› Verified 6 days ago
| Entity Name | Upmc Western Maryland Health Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447976584 PECOS PAC ID: 7113396011 Enrollment ID: O20221216000041 |
News Archive
According to a recent study, following a high Glycemic Index (GI) diet may increase a persons risk of fatty liver disease.
To discriminate between patients with severe and non-severe COVID-19 quickly, researchers from Peru looked for prognostic signatures in the blood samples of COVID-19 patients. Virgilio E. Failoc-Rojas et al. examined laboratory results and clinical prognosis of COVID-19 patients from a hospital in the Peruvian Amazon.
Serono and IVAX Corporation has announced positive results from two clinical trials with a new proprietary oral formulation of cladribine, a potential new treatment for multiple sclerosis (MS). The study results showed that the formulation of oral cladribine which has been developed by Serono and IVAX has met the targets for an orally administered product, with blood levels of cladribine in the expected therapeutic range. Efficacy studies of oral cladribine in MS patients are planned to start late 2004.
Ten months into the coronavirus disease (COVID-19) pandemic, health experts have a good understanding of how the virus spreads. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spreads through respiratory droplets and aerosols and enters the body through the mouth, nose, and eyes.
Certain fragments of DNA shed by tumors into the bloodstream can potentially be used to non-invasively screen for early-stage cancers, monitor responses to treatment and help explain why some cancers are resistant to therapies, according to results of an international study led by Johns Hopkins Kimmel Cancer Center investigators.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Richard Gerard Schmitt, MD Po Box 1671, Cumberland, MD 21501-1671 Ph: (240) 964-8342 | Dr Richard Gerard Schmitt, MD 12502 Willowbrook Rd, S, Cumberland, MD 21502-6393 Ph: (240) 964-8690 |
News Archive
According to a recent study, following a high Glycemic Index (GI) diet may increase a persons risk of fatty liver disease.
To discriminate between patients with severe and non-severe COVID-19 quickly, researchers from Peru looked for prognostic signatures in the blood samples of COVID-19 patients. Virgilio E. Failoc-Rojas et al. examined laboratory results and clinical prognosis of COVID-19 patients from a hospital in the Peruvian Amazon.
Serono and IVAX Corporation has announced positive results from two clinical trials with a new proprietary oral formulation of cladribine, a potential new treatment for multiple sclerosis (MS). The study results showed that the formulation of oral cladribine which has been developed by Serono and IVAX has met the targets for an orally administered product, with blood levels of cladribine in the expected therapeutic range. Efficacy studies of oral cladribine in MS patients are planned to start late 2004.
Ten months into the coronavirus disease (COVID-19) pandemic, health experts have a good understanding of how the virus spreads. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spreads through respiratory droplets and aerosols and enters the body through the mouth, nose, and eyes.
Certain fragments of DNA shed by tumors into the bloodstream can potentially be used to non-invasively screen for early-stage cancers, monitor responses to treatment and help explain why some cancers are resistant to therapies, according to results of an international study led by Johns Hopkins Kimmel Cancer Center investigators.
› Verified 6 days ago
Dr. Feiyu Hong, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 12500 Willowbrook Rd, Cumberland, MD 21502 Phone: 240-964-7000 | |
Dr. Robustiano Jocson Barrera Jr., M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 200 Glenn Street, Suite #302, Cumberland, MD 21502 Phone: 240-522-0470 Fax: 240-522-0471 | |
Dr. James B. Deren, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1050 W Industrial Blvd, Cumberland, MD 21502 Phone: 240-964-9355 Fax: 240-964-9356 | |
Dr. Christopher Haas, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 12502 Willowbrook Rd, Suite 330, Cumberland, MD 21502 Phone: 240-964-8740 | |
Sunil Kumar Gupta, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 625 Kent Ave Ste 101, Cumberland, MD 21502 Phone: 301-724-7117 | |
Dr. Qamar Ul Zaman, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 12502 Willowbrook Rd, Suite 440, Cumberland, MD 21502 Phone: 301-777-3111 Fax: 301-777-0963 | |
Dr. Gregg C Donaldson, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 912 Seton Dr, Cumberland, MD 21502 Phone: 301-722-3111 Fax: 301-722-5135 |